Clinical trial

BI 671800 ED in Steroid-naive Asthmatic Patients

NCT01092143

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-03-18

PhasePHASE2

Study timeline

Study start (actual)2010-03-18Date precision: day

Registry last updated2022-05-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

BI 671800DRUG

Fluticasone propionate placeboDRUG

Fluticasone propionateDRUG · verified · RxNorm: fluticasone propionate

BI 671800 PlaceboDRUG

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

TaipeiTaiwan6 SeoulSouth Korea5 TaichungTaiwan3 St LouisMissouri, United States2 TorontoOntario, Canada2 GreenvilleSouth Carolina, United States2 QuébecQuebec, Canada2 BogotáColombia2 HoustonTexas, United States1 Los AngelesCalifornia, United States1 PhiladelphiaPennsylvania, United States1 DallasTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01092143 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.